00656.HK --

News

More News

  • Wolves Academy Partner with Chicago City Soccer Club

    2021-11-29

    Wolves have joined in partnership with Chicago City Soccer Club to collaborate and nurture some of the best talents in the UK and America.

  • “S&P Dow Jones Indices” releasesFosun International’s ESG score report:Fosun International’s ESG score improves significantly

    2021-11-26

    (Hong Kong, 26 November 2021) Fosun International Limited (HKEX stock code: 00656) has recently received an update on its S&P Dow Jones Indices ESG score, which improved significantly over the last year and is higher than the industry average. Fosun International’s performance beats more than 80% of its global peers in supply chain management, environmental policy and management systems, labor practice indicators, humancapital development, risk and crisis management, as well as other fields.

  • Fosun Participates in the Inaugural Asia Summit on Global Health, Actively Promoting Collaborations in Global Health

    2021-11-24

    "In the future construction of the health systems, we should focus on three aspects: first, the development of rapid, large-scale and low-cost testing capabilities; second, the easy access to vaccination; third, medical institutions must be well-equipped to quickly respond to infectious diseases such as COVID-19."

  • Lanvin Group Unveils New Brand Identity

    2021-11-22

    SHANGHAI, China, 22 November 2021 - Lanvin Group (the “Group”), the global luxury fashion group, today officially unveiled its new brand identity following the change of its name from Fosun Fashion Group. The adoption of the globally recognizable Lanvin brand as its new name represents a clear statement of the Group’s intent to build a global portfolio of iconic luxury fashion brands.

  • Nature: Making Biologic Medicines More Accessible

    2021-11-22

    Global biopharmaceutical company Henlius aims to greatly improve patient well-being with affordable and innovative biologic medicines.Henlius has built an integrated biopharmaceutical platform with high efficiency and innovation embedded throughout the product life cycle.Credit: HenliusPatients with cancer or autoimmune diseases often deal with long periods of debilitating